U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump

22 Nov 2020 / 09:35 H.

    Nov 21 (Reuters) - The U.S. Food and Drug Administration on Saturday issued an emergency use authorization for Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.

    (Reporting by Rama Venkat and Manas Mishra in Bengaluru; Editing by Dan Grebler)

    email blast